pyridoxine has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Vacarezza, R | 1 |
| Dolgushin, MV; Gushchin, AS; Sobolev, VG | 1 |
| Borja, MS; Davies, SS; Huang, J; Kon, V; Linton, MF; Smith, LE; Tao, H; Yancey, PG | 1 |
1 review(s) available for pyridoxine and mocetinostat
| Article | Year |
|---|---|
[Preleukemic states].
Topics: Adrenal Cortex Hormones; Aged; Alkaline Phosphatase; Androgens; Antineoplastic Agents; Blood Cell Count; Blood Transfusion; Chromosome Aberrations; Chromosome Disorders; Folic Acid; Humans; Leukocytes; Middle Aged; Muramidase; Myeloproliferative Disorders; Peroxidase; Preleukemia; Prognosis; Pyridoxine; Vitamin B 12 | 1982 |
2 other study(ies) available for pyridoxine and mocetinostat
| Article | Year |
|---|---|
[Morpho-functional analysis of blood leukocytes after isoniazid administration].
Topics: Administration, Oral; Adrenal Cortex; Animals; Antitubercular Agents; Isoniazid; Lymphocytes; Lysosomes; Male; Neutrophils; Peroxidase; Phagocytosis; Pyridoxine; Rats; Vitamin B Complex | 2012 |
Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
Topics: Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Aryldialkylphosphatase; ATP Binding Cassette Transporter 1; Benzylamines; Disease Models, Animal; Free Radical Scavengers; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Macrophages; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Peroxidase; Pyridoxine | 2020 |